Your browser doesn't support javascript.
loading
Combined type-1 plasminogen activator inhibitor and NOD2/CARD15 genotyping predicts complicated Crohn's disease behaviour.
Alvarez-Lobos, M; Arostegui, J I; Sans, M; Tassies, D; Piu, J; Reverter, J C; Pique, J M; Yagüe, J; Panés, J.
Affiliation
  • Alvarez-Lobos M; Department of Gastroenterology, Hospital Clinic, CIBER-HEPAD, Barcelona, Spain.
Aliment Pharmacol Ther ; 25(4): 429-40, 2007 Feb 15.
Article in En | MEDLINE | ID: mdl-17269998
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Polymorphism, Genetic / Crohn Disease / Plasminogen Activator Inhibitor 1 / Genetic Predisposition to Disease / Nod2 Signaling Adaptor Protein Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Aliment Pharmacol Ther Journal subject: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2007 Document type: Article Affiliation country: España Country of publication: Reino Unido
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Polymorphism, Genetic / Crohn Disease / Plasminogen Activator Inhibitor 1 / Genetic Predisposition to Disease / Nod2 Signaling Adaptor Protein Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Aliment Pharmacol Ther Journal subject: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2007 Document type: Article Affiliation country: España Country of publication: Reino Unido